|
ETDF
|
Cancer Myeloproliferative Disorders
|
30000
325870
410
434870
50
57500
5780
600
675960
950
97500
|
|
ETDF
|
Cancer Nasopharyngeal
|
22500
320
352930
422530
434530
5000
563190
60000
620
70
850
|
|
ETDF
|
Cancer Nervous System Neoplasms
|
250
2500
334250
40
434870
527000
650
7500
930
96500
|
|
ETDF
|
Cancer Neuroblastoma
|
180
2120
2500
325870
40
434870
523010
55910
7500
780
87500
96500
|
|
ETDF
|
Cancer Oral
|
15750
434000
524370
52500
570
62500
682020
753070
80
95000
|
|
ETDF
|
Cancer Oropharyngeal
|
100
10890
204350
2500
434590
52500
709680
830
87500
95190
|
|
ETDF
|
Cancer Osteosarcoma
|
128000
140
202430
300
340000
450000
575370
719340
7500
830
|
|
ETDF
|
Cancer Otorhinolaryngologic
|
108200
217500
387500
410
434230
50
595470
701990
7500
900
|
|
ETDF
|
Cancer Ovarian
|
22500
434030
47500
527000
550
667000
70
752700
850
988900
|
|
ETDF
|
Cancer Pancreatic Exocrine and Islet Cell
|
150000
210500
219340
225150
434500
47500
500
515160
60
688290
|
|
ETDF
|
Cancer Parathyroid
|
2750
30
434370
480
519340
520
55910
613690
706530
7500
|
|
ETDF
|
Cancer Pheochromocytoma
|
115830
30890
3210
322500
434500
452500
490
60
697500
730
875350
|
|
ETDF
|
Cancer Prostate 2a
|
130
2250
325710
434160
527000
570
667000
742000
830
97500
|
|
ETDF
|
Cancer Rectal
|
150000
17500
27500
37500
434000
460
571000
840000
85000
95750
|
|
ETDF
|
Cancer Residual
|
15900
248000
434500
524370
52810
601270
610
62710
781090
97530
|
|
ETDF
|
Cancer Rhabdomyosarcoma
|
120
205690
270
317250
34210
412500
692500
776950
838250
9330
|
|
ETDF
|
Cancer Sarcoma General Resonant Light Alternate program
|
10000
10240
13720
15610
1970
2040
2100
2490
3170
5000
5570
6000
8030
|
|
ETDF
|
Cancer Sezary Syndrome
|
17500
180
2120
2330
300
375170
434000
45750
475000
527000
662710
723010
|
|
ETDF
|
Cancer Squamous Cell Carcinoma
|
125000
150
20000
2120
375750
434330
45150
563190
73300
96500
|
|
ETDF
|
Cancer Stomach
|
125150
15030
2120
2500
30
434910
647000
789000
96500
985670
|
